Català-Solsona Judit, Miñano-Molina Alfredo J, Rodríguez-Álvarez José
Departament de Bioquímica i Biologia Molecular, Institut de Neurociències, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Front Mol Neurosci. 2021 Nov 22;14:786226. doi: 10.3389/fnmol.2021.786226. eCollection 2021.
Long-lasting changes of synaptic efficacy are largely mediated by activity-induced gene transcription and are essential for neuronal plasticity and memory. In this scenario, transcription factors have emerged as pivotal players underlying synaptic plasticity and the modification of neural networks required for memory formation and consolidation. Hippocampal synaptic dysfunction is widely accepted to underlie the cognitive decline observed in some neurodegenerative disorders including Alzheimer's disease. Therefore, understanding the molecular pathways regulating gene expression profiles may help to identify new synaptic therapeutic targets. The nuclear receptor 4A subfamily (Nr4a) of transcription factors has been involved in a variety of physiological processes within the hippocampus, ranging from inflammation to neuroprotection. Recent studies have also pointed out a role for the activity-dependent nuclear receptor subfamily 4, group A, member 2 (Nr4a2/Nurr1) in hippocampal synaptic plasticity and cognitive functions, although the underlying molecular mechanisms are still poorly understood. In this review, we highlight the specific effects of Nr4a2 in hippocampal synaptic plasticity and memory formation and we discuss whether the dysregulation of this transcription factor could contribute to hippocampal synaptic dysfunction, altogether suggesting the possibility that Nr4a2 may emerge as a novel synaptic therapeutic target in brain pathologies associated to cognitive dysfunctions.
突触效能的持久变化很大程度上由活动诱导的基因转录介导,对神经元可塑性和记忆至关重要。在这种情况下,转录因子已成为突触可塑性以及记忆形成和巩固所需神经网络修饰的关键参与者。海马突触功能障碍被广泛认为是包括阿尔茨海默病在内的一些神经退行性疾病中观察到的认知衰退的基础。因此,了解调节基因表达谱的分子途径可能有助于识别新的突触治疗靶点。转录因子核受体4A亚家族(Nr4a)已参与海马体内从炎症到神经保护的各种生理过程。最近的研究还指出,尽管其潜在分子机制仍知之甚少,但活性依赖性核受体亚家族4A成员2(Nr4a2/Nurr1)在海马突触可塑性和认知功能中发挥作用。在本综述中,我们强调了Nr4a2在海马突触可塑性和记忆形成中的特定作用,并讨论了该转录因子的失调是否可能导致海马突触功能障碍,总体上表明Nr4a2可能成为与认知功能障碍相关的脑部疾病中新的突触治疗靶点的可能性。